Grimes & Company, Inc. Novo Nordisk A S Transaction History
Grimes & Company, Inc.
- $3.93 Billion
- Q3 2025
A detailed history of Grimes & Company, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Grimes & Company, Inc. holds 113,752 shares of NVO stock, worth $5.69 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
113,752
              Previous 125,356
              
        
           9.26%
        
      
          
        Holding current value
$5.69 Million
            Previous $8.65 Million
            
        
           27.05%
        
      
          
        % of portfolio
0.16%
            Previous 0.24%
          
        Shares
	  33 transactions
	
  Others Institutions Holding NVO
# of Institutions
1,705Shares Held
294MCall Options Held
13.7MPut Options Held
19.7M- 
    
      Bank Of America Corp Charlotte, NC14.7MShares$737 Million0.08% of portfolio
- 
    
      Morgan Stanley New York, NY14.3MShares$715 Million0.07% of portfolio
- 
    
      Loomis Sayles & CO L P12.6MShares$629 Million1.12% of portfolio
- 
    
      Capital International Investors Los Angeles, CA11.6MShares$582 Million0.14% of portfolio
- 
    
      Ken Fisher Fisher Asset Management, LLC | Camas, Wa11MShares$550 Million0.31% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $113B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...